SCHEMBL12204174

SCHEMBL12204174

Pc1ncc(-c2cn[nH]c2)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT2 P31751 5/20 0.50
▸ AKT1 P31749 2/20 0.50
▸ CHEK1 O14757 3/20 0.46
▸ CHEK2 O96017 3/20 0.46
▸ ABL1 P00519 1/20 0.46
▸ ACVR1 Q04771 1/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ PIM1 P11309 2/20 0.38
▸ PIM3 Q86V86 2/20 0.38
▸ PIM2 Q9P1W9 2/20 0.38
▸ ILK Q13418 1/20 0.37
▸ LRRK2 Q5S007 1/20 0.37
▸ MAPK8 P45983 1/20 0.37
▸ FEN1 P39748 1/20 0.36
▸ AURKA O14965 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36
▸ INCENP Q9NQS7 1/20 0.36
▸ TPX2 Q9ULW0 1/20 0.36
▸ AKT3 Q9Y243 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3740850 0.80 AKT2 (0.70) AKT2AKT1CHEK1CHEK2ABL1
SCHEMBL12204196 0.77 AKT2 (0.50) AKT2AKT1CHEK1CHEK2ABL1
SCHEMBL12203913 0.77 AKT2 (0.50) AKT2AKT1CHEK1CHEK2ABL1
SCHEMBL26953475 0.77 AKT2 (0.50) AKT2AKT1CHEK1CHEK2ABL1
Hydrochloric Acid SCHEMBL28973063 0.77 AKT2 (0.67) AKT2AKT1CHEK1CHEK2ABL1
SCHEMBL6196346 0.75 — —
SCHEMBL29638874 0.73 AKT2 (0.56) AKT2AKT1CHEK1CHEK2ABL1
SCHEMBL15044972 0.72 AKT1 (0.45) AKT2AKT1CHEK1CHEK2ABL1
SCHEMBL26950615 0.72 AKT1 (0.45) AKT2AKT1CHEK1CHEK2ABL1
SCHEMBL29533228 0.72 AKT2 (0.61) AKT2AKT1CHEK1CHEK2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229356-B1 1,2-DISUBSTITUTED-4-BENZYLAMINO-PYRROLIDINE DERIVATIVES AS CETP INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES SUCH AS HYPERLI PIDEMIA OR ARTERIOSCLEROSIS NOVARTIS AG (CH) 2011-10-12 — — EP disclosed
Send feedback